2021 연구자 정보 (25 / 1141)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Kalra, Mannudeep K. (Kalra, MK) |
교신저자 | Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA |
LXW-4237-2024 Kalra, Mannudeep |
|
[JCR상위 1.3%] Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19 [JCR상위 32.0%] A multi-center study of COVID-19 patient prognosis using deep learning-based CT image analysis and electronic health records |
SCIE | 1.3 |
COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS ENGINEERING, BIOMEDICAL RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING |
li.quanzheng@mgh.harvard.edu MKALRA@mgh.harvard.edu Li.Quanzheng@mgh.harvard.edu |
|
|
Kim, Younggon (Kim, YG) |
Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA |
|
|
[JCR상위 1.3%] Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19 | SCIE | 1.3 |
COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS ENGINEERING, BIOMEDICAL RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING |
li.quanzheng@mgh.harvard.edu | ||
|
Li, Xiang (Li, X) |
Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Ctr Adv Med Comp & Anal, Boston, MA 02115 USA |
J-6924-2019 Li, Xiang |
0000-0002-9851-6376 Li, Xiang |
[JCR상위 1.3%] Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19 [JCR상위 0.2%] Federated learning for predicting clinical outcomes in patients with COVID-19 |
SCIE | 0.2 |
COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS ENGINEERING, BIOMEDICAL RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING BIOCHEMISTRY & MOLECULAR BIOLOGY CELL BIOLOGY MEDICINE, RESEARCH & EXPERIMENTAL |
li.quanzheng@mgh.harvard.edu mflores@nvidia.com |
||
|
Neumark, Nir (Neumark, N) |
MGH & BWH Ctr Clin Data Sci, Boston, MA 02114 USA MGH & BWH Ctr Clin Data Sci, Boston, MA USA |
|
|
[JCR상위 1.3%] Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19 [JCR상위 32.0%] A multi-center study of COVID-19 patient prognosis using deep learning-based CT image analysis and electronic health records |
SCIE | 1.3 |
COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS ENGINEERING, BIOMEDICAL RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING |
li.quanzheng@mgh.harvard.edu MKALRA@mgh.harvard.edu Li.Quanzheng@mgh.harvard.edu |
||
|
Ren, Hui (Ren, H) |
Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Ctr Adv Med Comp & Anal, Boston, MA 02115 USA |
|
0000-0003-0710-231X Ren, Hui |
[JCR상위 1.3%] Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19 [JCR상위 32.0%] A multi-center study of COVID-19 patient prognosis using deep learning-based CT image analysis and electronic health records [JCR상위 0.2%] Federated learning for predicting clinical outcomes in patients with COVID-19 |
SCIE | 0.2 |
COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS ENGINEERING, BIOMEDICAL RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING BIOCHEMISTRY & MOLECULAR BIOLOGY CELL BIOLOGY MEDICINE, RESEARCH & EXPERIMENTAL |
li.quanzheng@mgh.harvard.edu MKALRA@mgh.harvard.edu Li.Quanzheng@mgh.harvard.edu mflores@nvidia.com |
||
|
Zhong, Aoxiao (Zhong, AX) |
제1저자 |
Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA Harvard Univ, Sch Engn & Appl Sci, Boston, MA USA Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Ctr Adv Med Comp & Anal, Boston, MA 02115 USA Harvard Univ, Sch Engn & Appl Sci, Boston, MA 02115 USA |
|
0000-0002-7584-5476 Zhong, Aoxiao |
[JCR상위 1.3%] Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19 [JCR상위 0.2%] Federated learning for predicting clinical outcomes in patients with COVID-19 |
SCIE | 0.2 |
COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS ENGINEERING, BIOMEDICAL RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING BIOCHEMISTRY & MOLECULAR BIOLOGY CELL BIOLOGY MEDICINE, RESEARCH & EXPERIMENTAL |
li.quanzheng@mgh.harvard.edu mflores@nvidia.com |
|
|
Abou-Alfa, Ghassan K. (Abou-Alfa, GK) |
Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA |
|
|
[JCR상위 1.4%] Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliarytract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study | SCIE | 1.4 | ONCOLOGY | yooc@amc.seoul.kr | ||
|
Cheon, Jaekyung (Cheon, J) |
Univ Ulsan, Asan Med Ctr, Ulsan Univ Hosp, Coll Med, Seoul, South Korea Univ Ulsan, Div Hematol & Oncol, Ulsan Univ Hosp, Coll Med,Dept Internal Med, Seoul, South Korea |
|
|
[JCR상위 1.4%] Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliarytract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study | SCIE | 1.4 | ONCOLOGY | yooc@amc.seoul.kr | ||
|
Jeong, Jae Ho (Jeong, JH) |
Univ Ulsan, Coll Med, Dept Oncol, Seoul, South Korea |
|
|
[JCR상위 1.4%] Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliarytract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study | SCIE | 1.4 | ONCOLOGY | yooc@amc.seoul.kr | ||
|
Kang, Myoung Joo (Kang, MJ) |
Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Div Oncol,Coll Med, Busan, South Korea |
|
|
[JCR상위 1.4%] Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliarytract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study | SCIE | 1.4 | ONCOLOGY | yooc@amc.seoul.kr | ||
|
Kim, Ilhwan (Kim, I) |
Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Div Oncol,Coll Med, Busan, South Korea |
AGF-2385-2022 Kim, In-Ryoung |
|
[JCR상위 1.4%] Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliarytract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study | SCIE | 1.4 | ONCOLOGY | yooc@amc.seoul.kr | ||
|
Kim, Kyu-Pyo (Kim, KP) |
Univ Ulsan, Coll Med, Dept Oncol, Seoul, South Korea Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea |
GQH-5608-2022 Kim, Hyunho |
|
[JCR상위 1.4%] Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliarytract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study [JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma |
SCIE | 0.7 |
ONCOLOGY MULTIDISCIPLINARY SCIENCES |
yooc@amc.seoul.kr twkimmd@amc.seoul.kr shivam@gene.com |
||
|
Kim, Kyung Won (Kim, KW) |
Univ Ulsan, Asan Image Metr, Asan Inst Life Sci, Clin Res Ctr,Coll Med, Seoul, South Korea |
|
|
[JCR상위 1.4%] Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliarytract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study | SCIE | 1.4 | ONCOLOGY | yooc@amc.seoul.kr | ||
|
Ryu, Hyewon (Ryu, H) |
Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Internal Med, Div Hematol & Oncol,Coll Med, Daejeon, South Korea |
|
|
[JCR상위 1.4%] Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliarytract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study | SCIE | 1.4 | ONCOLOGY | yooc@amc.seoul.kr | ||
|
Angelidaki, Irini (Angelidaki, I) |
Tech Univ Denmark, Dept Chem Engn, Lyngby, Denmark |
AAX-2562-2020 Angelidaki, Irini |
0000-0002-6357-578X Angelidaki, Irini |
[JCR상위 1.5%] Quorum quenching, biological characteristics, and microbial community dynamics as key factors for combating fouling of membrane bioreactors | SCIE | 1.5 |
ENGINEERING, CHEMICAL ENVIRONMENTAL SCIENCES WATER RESOURCES |
chookh@knu.ac.kr |
페이지 이동: